Publication
Our Publication
Other Publication
Events
Conference
Seminar & Workshop
Collabortion
Interdiscplinary Partners
National Partners
InterNational Partners?
Services
Research
Clinical
Overview
How To Apply
Related Links
Related Links
Grants
Grants From Tanta University
Grants From National Resources
Grants From InterNational Resources
Album
Meeting Photo
Conference Photo
Workshop Photo
News
News
FAQ
FAQ
Register
1.Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibodies perspective
http://www.oncologyreviews.org/article/view/256
major-bid
2. The p53/microRNA connection in gastrointestinal cancer
http://www.dovepress.com/articles.php?article_id=18580
3.Homozygosity for HLA Group 2 Alleles Predicts Treatment Failure with Interferon-α and Ribavirin in Chronic Hepatitis C Virus Genotype 1 Infection
http://online.liebertpub.com/doi/abs/10.1089/jir.2014.0088
4.Journal of Interferon & Cytokine Research
http://www.liebertpub.com/overview/journal-of-interferon-brand-cytokine-
5.An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma
http://www.dovepress.com/articles.php?article_id=18558
6.Systemic Cytokine and Interferon Responsiveness Patterns in HIV and HCV Mono and Co-Infections
http://online.liebertpub.com/doi/abs/10.1089/jir.2014.0006
7.Impact of Vitamin D Supplementation on Sustained Virological Response in Chronic Hepatitis C Genotype 4 Patients Treated by Pegylated Interferon/Ribavirin
http://online.liebertpub.com/doi/abs/10.1089/jir.2014.0060
8.Human Monocytes in the Presence of Interferons Alpha2a and Gamma Are Potent Killers of Serous Ovarian Cancer Cell Lines in Combination with Paclitaxel and Carboplatin
http://online.liebertpub.com/doi/abs/10.1089/jir.2014.0057
9.The Role of Cytokines in Breast Cancer Development and Progression
http://online.liebertpub.com/doi/abs/10.1089/jir.2014.0026
10. Interleukin-21 Responses in Patients with Chronic Hepatitis B
http://online.liebertpub.com/doi/abs/10.1089/jir.2013.0119
11. Transcription of Inflammatory Genes: Long Noncoding RNA and Beyond
http://online.liebertpub.com/doi/abs/10.1089/jir.2014.0120?journalCode=jir#utm_source=PR&utm_medium=email&utm_campaign=JIR
12.Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
http://www.cell.com/trends/biochemical-sciences/abstract/S0968-0004(14)00153-4
13.developing novel immunotherapy for cd19+ leukemia and lymphoma
http://www.nfcr.org/laurence-jn-cooper-md-phd-md-anderson-cancer-center?&utm_medium=email&utm_source=nfcr&utm_content=1&utm_campaign=EQK899AC&source=EQK899AC
14. Findings point to an "off switch" for drug resistance in cancer
http://www.salk.edu/news/pressrelease_details.php?press_id=2056
15.PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs
http://www.dovepress.com/articles.php?article_id=18676
16.Adaptive Trial Designs to AdvanceOncology Research
http://vertassets.blob.core.windows.net/download/683e69ca/683e69ca-b578-46c5-b8bd-2d2fd5732012/adaptivetrialdesigns.pdf
17.The Challenge: Making Adaptive Clinical Trials Operational
http://www.clinicalleader.com/doc/the-challenge-making-adaptive-clinical-trials-operational-0001?sectionCode=Articles&templateCode=Single&user=2883698&source=nl%3A41405&utm_source=et_6212879&utm_medium=email&utm_campaign=CLNCL_2014-10-08&utm_term=E06D5844-6D53-4BA6-8C2F-7B7025748377&utm_content=The%2BChallenge%253a%2BMaking%2BAdaptive%2BClinical%2BTrials%2BOperational
18.Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials
http://www.dovepress.com/articles.php?article_id=18668
19.Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancer
http://www.dovepress.com/articles.php?article_id=18636
20.Prognostic value of preoperative absolute lymphocyte count in recurrent hepatocellular carcinoma following thermal ablation: a retrospective analysis
http://www.dovepress.com/articles.php?article_id=18602
21.Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer
http://www.dovepress.com/articles.php?article_id=18600
22.Colorectal cancer in Chinese patients: current and emerging treatment options
http://www.dovepress.com/articles.php?article_id=18599
23. Clinical trial design in the era of comparative effectiveness research
http://www.dovepress.com/articles.php?article_id=18634
24- Immunotherapy Yields Response in Triple-Negative Breast Cancer
http://www.cancernetwork.com/sabcs-2014/immunotherapy-yields-response-triple-negative-breast-cancer#sthash.tqeWlnbn.dpuf
25-Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response
http://www.jci.org/articles/view/77990
26-Targeting cancer with kinase inhibitors
http://www.jci.org/articles/view/76094
27- Wnt blockers inhibit the proliferation of lung cancer stem cells
http://www.dovepress.com/articles.php?article_id=21510
28-Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response
http://www.jci.org/articles/view/77990
29- Targeting cancer with kinase inhibitors
http://www.jci.org/articles/view/76094
30-Wnt blockers inhibit the proliferation of lung cancer stem cells
http://www.dovepress.com/articles.php?article_id=21510